Does obesity increase cancer risk?
Strong EvidenceYES
Strong evidence from IARC working groups, large prospective cohorts, and dose-response meta-analyses establishes excess body fat as a causal risk factor for at least 13 cancer types, with risk increasing progressively with BMI.
The Verdict
Strong evidence from IARC working groups, large prospective cohorts, and dose-response meta-analyses establishes excess body fat as a causal risk factor for at least 13 cancer types, with risk increasing progressively with BMI.
What the Evidence Shows
The relationship between obesity and cancer has been comprehensively evaluated by the International Agency for Research on Cancer (IARC). In 2016, an IARC working group reviewed over 1,000 epidemiological studies and concluded there is sufficient evidence that excess body fatness causes cancer at 13 anatomical sites: esophagus (adenocarcinoma), gastric cardia, colon, rectum, liver, gallbladder, pancreas, breast (postmenopausal), corpus uteri, ovary, kidney (renal cell), meningioma, thyroid, and multiple myeloma. Renehan's landmark meta-analysis quantified dose-response relationships, finding that each 5 kg/m² increase in BMI was significantly associated with increased risk for multiple cancer types, with the strongest associations for endometrial cancer (RR 1.59 per 5 BMI units) and kidney cancer (RR 1.24). Bhaskaran's population-based study of 5.24 million UK adults confirmed associations with 17 of 22 specific cancers examined. The biological mechanisms are well-characterized: excess adiposity promotes chronic low-grade inflammation, insulin resistance with elevated insulin and IGF-1 (mitogenic hormones), increased estrogen production from aromatization in adipose tissue, altered adipokine profiles, and creation of a tumor-promoting microenvironment. Approximately 4-8% of all cancers in developed countries are attributable to obesity.
Evidence Quality
4
Meta-Analyses
0
RCTs
20
Observational
Important Caveats
- ⚠️ The obesity paradox—some studies show overweight (BMI 25-30) associated with lower mortality in certain cancers post-diagnosis
- ⚠️ Mechanisms vary by cancer type—not all obesity-cancer links share the same biological pathway
- ⚠️ Weight loss intervention trials have not yet definitively proven cancer risk reduction (though bariatric surgery data is suggestive)
- ⚠️ BMI is an imperfect measure of adiposity—body fat distribution matters (visceral vs. subcutaneous)
- ⚠️ Confounding by physical inactivity, diet quality, and socioeconomic factors is difficult to fully eliminate
Population Studied
Global populations; IARC reviewed >1,000 studies worldwide; Bhaskaran analyzed 5.24 million UK adults; Renehan meta-analyzed 282 studies across multiple continents
Dosage
Dose-response: each 5 kg/m² increase in BMI associated with 2-59% higher risk depending on cancer site; visceral adiposity (waist circumference) may be a stronger predictor than BMI
Duration
Prospective cohort studies with 5-20 years follow-up; cancer risk accumulates with years of excess adiposity; some evidence suggests timing matters (adult weight gain vs. childhood obesity)
Supporting Studies (3)
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Meta-AnalysisLauby-Secretan B, Scoccianti C, Loomis D, et al. · New England Journal of Medicine (2016)
IARC working group review of >1,000 studies concluded there is sufficient evidence that excess body fatness causes cancer at 13 anatomical sites, establishing obesity as a major modifiable cancer risk factor alongside tobacco and alcohol.
View paper (DOI) →Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Meta-AnalysisRenehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. · Lancet (2008)
Meta-analysis of 282 studies found significant dose-response associations between BMI and cancer risk at multiple sites, with each 5 kg/m² increase associated with elevated risk for endometrial (RR 1.59), kidney (RR 1.24), gallbladder, and esophageal cancers.
View paper (DOI) →Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults
ObservationalBhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. · Lancet (2014)
In 5.24 million UK adults, higher BMI was associated with significantly increased risk of 17 of 22 specific cancers, with population attributable fractions suggesting 12,000+ annual UK cancer cases attributable to excess weight.
View paper (DOI) →Contradicting Studies (1)
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories: A Systematic Review and Meta-analysis
Meta-AnalysisFlegal KM, Kit BK, Orpana H, Graubard BI. · JAMA (2013)
Meta-analysis of 97 studies found that overweight (BMI 25-30) was associated with significantly LOWER all-cause mortality than normal weight, and grade 1 obesity (BMI 30-35) was not associated with higher mortality—the so-called 'obesity paradox.'
Why this disagrees:
Challenges the simple 'more fat = more disease' narrative by showing that moderate overweight may actually be protective for all-cause mortality, suggesting the BMI-cancer relationship may be confounded by reverse causation (illness causing weight loss) or that cancer risk increases only at higher obesity thresholds.
Related Claims
Does excess sugar intake increase type 2 diabetes risk?
Strong EvidenceStrong epidemiological evidence consistently links high sugar-sweetened beverage consumption to increased type 2 diabetes risk, with approximately 26% higher risk per daily serving, independent of obesity.
Does regular exercise reduce cancer risk?
Strong EvidenceStrong evidence from large pooled analyses demonstrates that regular physical activity is associated with reduced risk of at least 13 cancer types, with risk reductions ranging from 10-42% depending on cancer site.
Does the Mediterranean diet reduce cardiovascular risk?
Strong EvidenceStrong evidence from large RCTs and meta-analyses shows the Mediterranean diet significantly reduces cardiovascular events, including heart attacks and strokes, by approximately 30% compared to control diets.